GE Healthcare and Cardinal ask Cali court to drop antitrust suit
GE Healthcare and Cardinal asked a California federal judge to drop an antitrust lawsuit accusing the healthcare giants of conspiring to creating a monopoly for cardiac imaging agents.
GE Healthcare and Cardinal team up in imaging agent antitrust suit
GE Healthcare (NYSE:GE) and Cardinal Health joined in asking a California federal judge to dismiss a class action lawsuit alleging that their distribution of a cardiac imaging agent violates antitrust statutes.
The lawsuit, filed by PharmaRx Pharmaceutical Inc., accuses GE Healthcare and preventing radiopharmacies from purchasing Myoview and Cardinal of Cardiolite in a "conspiracy to eliminate competition in the market for nuclear cardiac imaging agents," according to court documents.